Chargement en cours...
Biomarkers in management of inflammatory bowel disease
In recent years the use of faecal and serologic biomarkers has been evaluated in the diagnosis and management of inflammatory bowel disease (IBD). Faecal calprotectin (FC) has been proposed as a surrogate marker for intestinal inflammation; elevated concentrations in IBD patients have been confirmed...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Termedia Publishing House
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4027818/ https://ncbi.nlm.nih.gov/pubmed/24868269 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/pg.2013.38728 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|